REPORTS

Let’s Pullulate and Expand Your Business

Edible Vaccine Market - Global Professional Analysis and Forecast to 2026

Nov 18, 2019  |  136 PAGES  |  REPORT CODE: CMM241771
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Edible Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.9% during the forecast period.

This report presents the market size and development trends by detailing the Edible Vaccine market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Edible Vaccine market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Edible Vaccine industry and will help you to build a panoramic view of the industrial development.

Edible Vaccine Market, By Type:

  • Type 1

  • Type 2

  • Type 3

Edible Vaccine Market, By Application:

  • End-User 1

  • End-User 2

  • End-User 3

Some of the leading players are as follows:

  • GlaxoSmithKline

  • Pfizer

  • MedImmune

  • BiondVax Pharmaceuticals

  • ALK-Abello A/S

  • Sanofi Pasteur SA

  • Hualan Biological Engineering

  • Shanghai BravoBio

  • Merck

  • Janssen Pharmaceuticals

  • Serum Institute of India

  • Altimmune

  • Bavarian Nordic A/S

  • Bharat Biotech International

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Edible Vaccine Market: Technology Type Analysis

  • 4.1 Edible Vaccine Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Edible Vaccine Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Type 1

    • 4.3.2 Type 2

    • 4.3.3 Type 3

5 Edible Vaccine Market: Product Analysis

  • 5.1 Edible Vaccine Product Market Share Analysis, 2018 & 2026

  • 5.2 Edible Vaccine Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Edible Vaccine Market: Application Analysis

  • 6.1 Edible Vaccine Application Market Share Analysis, 2018 & 2026

  • 6.2 Edible Vaccine Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 End-User 1

    • 6.3.2 End-User 1

    • 6.3.3 End-User 3

7 Edible Vaccine Market: Regional Analysis

  • 7.1 Edible Vaccine Regional Market Share Analysis, 2018 & 2026

  • 7.2 Edible Vaccine Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 GlaxoSmithKline

    • 9.1.1 GlaxoSmithKline Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Pfizer

    • 9.2.1 Pfizer Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 MedImmune

    • 9.3.1 MedImmune Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 BiondVax Pharmaceuticals

    • 9.4.1 BiondVax Pharmaceuticals Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 ALK-Abello A/S

    • 9.5.1 ALK-Abello A/S Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Sanofi Pasteur SA

    • 9.6.1 Sanofi Pasteur SA Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Hualan Biological Engineering

    • 9.7.1 Hualan Biological Engineering Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Shanghai BravoBio

    • 9.8.1 Shanghai BravoBio Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Merck

    • 9.9.1 Merck Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Janssen Pharmaceuticals

    • 9.10.1 Janssen Pharmaceuticals Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Serum Institute of India

    • 9.11.1 Serum Institute of India Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Altimmune

    • 9.12.1 Altimmune Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Bavarian Nordic A/S

    • 9.13.1 Bavarian Nordic A/S Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Bharat Biotech International

    • 9.14.1 Bharat Biotech International Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

 

The List of Tables and Figures (Totals 65 Figures and 138 Tables)

  • Figure Type 1 Edible Vaccine market, 2015 - 2026 (USD Million)

  • Figure Type 2 Edible Vaccine market, 2015 - 2026 (USD Million)

  • Figure Type 3 Edible Vaccine market, 2015 - 2026 (USD Million)

  • Figure End-User 1 market, 2015 - 2026 (USD Million)

  • Figure End-User 2 market, 2015 - 2026 (USD Million)

  • Figure End-User 3 market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Edible Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table North America Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table North America Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table North America Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Canada Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Canada Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Europe Edible Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Europe Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Europe Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Europe Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Germany Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Germany Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table France Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table France Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Italy Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Italy Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Spain Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Spain Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Edible Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table China Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table China Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Japan Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Japan Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table India Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table India Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Edible Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table MEA Edible Vaccine market, by country, 2015 - 2026 (USD Million)

  • Table MEA Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table MEA Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table MEA Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Edible Vaccine market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Edible Vaccine market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Edible Vaccine market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table MedImmune Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BiondVax Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ALK-Abello A/S Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Pasteur SA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Hualan Biological Engineering Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shanghai BravoBio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Janssen Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Altimmune Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bavarian Nordic A/S Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bharat Biotech International Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top